8-Prenylnaringenin inhibits epidermal growth factor-induced MCF-7 breast cancer cell proliferation by targeting phosphatidylinositol-3-OH kinase activity

Journal of Steroid Biochemistry and Molecular Biology

Volumn 113, Issue 3-5, 2009, Pages 163-170

  Brunelli, Elisa ^a   Pinton, Giulia ^a   Chianale, Federica ^a   Graziani, Andrea ^a   Appendino, Giovanni ^a   Moro, Laura ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

8 Prenylnaringenin; Breast cancer; EGFR receptor; Signalling

Indexed keywords

8 PRENYLNARINGENIN; CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RECOMBINANT EPIDERMAL GROWTH FACTOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CELL CYCLE ARREST; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL SURVIVAL; CONTROLLED STUDY; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BREAST NEOPLASMS; CELL LINE, TUMOR; CYCLIN D1; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; FLAVANONES; HUMANS; MOLECULAR STRUCTURE; PHYTOESTROGENS; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION;

EID: 61549102798     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2008.11.013     Document Type: Article

References (41)

1. Albini A., and Sporn M.B. The tumour microenvironment as a target for chemoprevention. Nat. Rev. Cancer 7 2 (2007) 139-147
2. Lambert J.D., Hong J., Yang G.Y., Liao J., and Yang C.S. Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations. Am. J. Clin. Nutr. 81 (2005) 284S-291S
3. Albini A., Dell'Eva R., Vené R., Ferrari N., Buhler D.R., Noonan D.M., and Fassina G. Mechanisms of the antiangiogenic activity by the hop flavonoid xanthohumol: NF-kB and Akt as targets. FASEB J. 20 3 (2006) 527-529
4. Milligan S.R., Kalita J.C., Pocock V., Van De Kauter V., Stevens J.F., Deinzer M.L., Rong H., De D., and Keukeleire. Identification of a potent phytoestrogen in hops (Humus lupulus L.) and beer. J. Clin. Endocrinol. Metab. 85 (1999) 4912-4915
5. Possemiers S., Heyerick A., Robbens V., De Keukeleire D., and Verstraete W. Activation of proestrogens from hops (Humus lupulus L.) by intestinal microbia; Conversion of isoxanthohumol into 8-prenylnaringenin. J. Agric. Food Chem. 53 16 (2005) 6281-6288
6. Stevens J.F., and Page J.E. Xanthohumol and related prenylflavonoids from hops and beer: to your good health!. Phytochemistry 65 (2004) 1317-1330
7. Pepper M.S., Hazel S.J., Huempel M., and Schleuning W.D. 8-Prenylnaringenin, a novel phytoestrogen, inhibits angiogenesis in vitro and in vivo. J. Cell. Physiol. 199 (2004) 98-107
8. Matsumura A., Ghosh A., Pope G.S., and Darbre P.D. Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells. J. Steroid Biochem. Mol. Biol. 94 (2005) 431-443
9. Schaefer O., Huempel M., Fritzemeier K.H., Bohlmann R., and Schleuning W.D. 8-Prenylnaringenin is a potent ERalpha selective phytoestrogen present in hops and beer. J. Steroid Biochem. Mol. Biol. 84 (2003) 359-360
10. Mangelsdorf D.J., et al. The nuclear receptor superfamily: the second decade. Cell 83 (1995) 835-839
11. Parker M.G., and White R. Nuclear receptors spring into action. Nat. Struct. Biol. 3 (1996) 113-115
12. Beato M., Herrlich P., and Schutz G. Steroid hormone receptors: many actors in search of a plot. Cell 83 6 (1995) 851-857
13. McKenna N.J., Lanz R.B., and O'Malley B.W. Nuclear receptor coregulators: cellular and molecular biology. Endocr. Rev. 20 (1999) 321-344
14. Marino M., Acconcia F., and Ascenzi P. Estrogen receptor signalling: bases for drug actions. Curr. Drug Targets Immune Endocr. Metab. Disord. 5 3 (2005) 305-314
15. Acconcia F., and Kumar R. Signaling regulation of genomic and nongenomic functions of estrogen receptors. Cancer Lett. 238 1 (2006) 1-14
16. Levin E.R. Integration of the extranuclear and nuclear actions of estrogen. Mol. Endocrinol. 19 8 (2005) 1951-1959
17. Migliaccio A., Di Domenico M., Castoria G., De Falco A., Bontempo P., Nola E., and Auricchio F. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J. 15 6 (1996) 1292-1300
18. Migliaccio A., Piccolo D., Castoria G., Di Domenico M., Bilancio A., Lombardi M., Gong W., Beato M., and Auricchio F. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J. 17 7 (1998) 2008-2018
19. Migliaccio A., Castoria G., Di Domenico M., De Falco A., Bilancio A., Lombardi M., Barone M.V., Ametrano D., Zannini M.S., Abbondanza C., and Auricchio F. Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation. EMBO J. 19 20 (2000) 5406-5417
20. Castoria G., Migliaccio A., Bilancio A., Di Domenico M., De Falco A., Lombardi M., Fiorentino R., Varricchio L., Barone M.V., and Auricchio F. PI3-kinase in concert with Src promotes the S-phase entry of estradiol-stimulated MCF-7 cells. EMBO J. 20 21 (2001) 6050-6059
21. Vanhaesebroeck B., Leevers S.J., Ahmadi K., Timms J., Katso R., Driscoll P.C., Woscholski R., Parker P.J., and Waterfield M.D. Synthesis and function of 3-phosphorylated inositol lipids. Annu. Rev. Biochem. 70 (2001) 535-602
22. Rameh L.E., and Cantley L.C. The role of phosphoinositide 3-kinase lipid products in cell function. J. Biol. Chem. 274 (1999) 8347-8350
23. Carpenter C.L., and Cantley L.C. Phosphoinositide kinases. Curr. Opin. Cell Biol. 8 2 (1996) 153-158
24. Downward J. Lipid-regulated kinases: some common themes at last. Science 279 (1998) 673-674
25. Marte B.M., and Downward J. PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem. Sci. 22 (1997) 355-358
26. Coffer P.J., Jin J., and Woodgett J.R. Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem. J. 335 (1998) 1-13
27. Manning B.D., and Cantley L.C. AKT/PKB signaling: navigating downstream. Cell 129 7 (2007) 1261-1274
28. Migliaccio A., Di Domenico M., Castoria G., Nanayakkara M., Lombardi M., De Falco A., Bilancio A., Varricchio L., Ciociola A., and Auricchio F. Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action. Cancer Res. 65 22 (2005) 10585-10593
29. Song R.X., and Santen R.J. Membrane initiated estrogen signaling in breast cancer. Biol. Reprod. 75 (2006) 9-16
30. Ankrapp D.P., Bennett J.M., and Haslam S.Z. Role of epidermal growth factor in the acquisition of ovarian steroid hormone responsiveness in the normal mouse mammary gland. J. Cell. Physiol. 174 (1998) 251-260
31. Curtis S.W., Washburn T., Sewall C., Di Augustine R., Lindzey J., Couse J.F., and Korach K.S. Physiological coupling of growth factor and steroid receptor signaling pathways: estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 12626-12630
32. Kurebayashi J., Okubo S., Yamamoto Y., and Sonoo H. Inhibition of HER1 signaling pathway enhances antitumor effect of endocrine therapy in breast cancer. Breast Cancer 11 (2004) 38-41
33. Brunelli E., Minassi A., Appendino G., and Moro L. 8-Prenylnaringenin, inhibits estrogen receptor-a mediated cell growth and induces apoptosis in MCF-7 breast cancer cells. J. Steroid Biochem. Mol. Biol. 107 (2007) 140-148
34. Anstead G.M., Carlson K.E., and Katzenellenbogen J.A. The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site. Steroids 62 3 (1997) 268-303
35. Blair R.M., Fang H., Branham W.S., Hass B.S., Dial S.L., Moland C.L., Tong W., Shi L., Perkins R., and Sheehan D.M. The estrogen receptor relative binding affinities of 188 natural and xenochemicals: structural diversity of ligands. Toxicol. Sci. 54 1 (2000) 138-153
36. Lobenhofer E.K., Huper G., Iglehart J.D., and Marks J.R. Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis. Cell Growth Differ. 11 (2000) 99-110
37. Marino M., Acconcia F., Bresciani F., Weisz A., and Trentalance A. Distinct nongenomic signal transduction pathways controlled by 17β-estradiol regulate DNA synthesis and cyclin D1 gene transcription in HepG2 cells. Mol. Biol. Cell 13 (2002) 3720-3729
38. Wang T.C., Cardiff R.D., Zukerberg L., Lees E., Arnold A., and Schmidt E.V. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369 (1994) 669-671
39. Fantl V., Stamp G., Andrews A., Rosewell I., and Dickson C. Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev. 9 (1995) 2364-2372
40. Di Domenico M., Castoria G., Bilancio A., Migliaccio A., and Auricchio F. Estradiol activation of human colon carcinoma-derived Caco-2 cell growth. Cancer Res. 56 19 (1996) 4516.A-4521.A
41. Graziani D., Gramaglia L.C., Cantley P.M., and Comoglio. The tyrosine-phosphorylated hepatocyte growth factor/scatter factor receptor associates with phosphatidylinositol 3-kinase. J. Biol. Chem. 266 33 (1991) 22087-22090